TABLE 1.
Patient demographics and baseline characteristics
| FAS (n = 1149) | |
|---|---|
| Age, mean (SD) | 53.9 (13.6) |
| Sex, n (%) | |
| Female | 483 (42.0) |
| Male | 666 (58.0) |
| Race, n (%) | |
| American Indian or Alaska native | 11 (1.0) |
| Asian | 64 (5.6) |
| Black or African American | 9 (0.8) |
| Multiple | 8 (0.7) |
| Unknown | 195 (17.0) |
| White | 862 (75.0) |
| Ethnicity, n (%) | |
| Hispanic or Latino | 10 (0.9) |
| Not Hispanic or Latino | 809 (70.4) |
| Unknown | 330 (28.7) |
| Age at psoriasis onset (years), mean (SD) | 34.0 (16.0) |
| Years since psoriasis onset, mean (SD) | 19.9 (13.3) |
| Height (cm), mean (SD) | 170.6 (10.1) |
| Weight (kg), mean (SD) | 91.8 (23.1) |
| BMI (kg/m2), mean (SD) | 31.2 (7.6) |
| Total treatment duration (years), mean (SD) | 4.6 (3.1) |
| Comorbidities, n (%) | |
| PsA | 297 (25.8) |
| Crohn’s disease | 11 (1.0) |
| Ulcerative colitis | 10 (0.9) |
| Uveitis | 4 (0.3) |
| Any other | 602 (52.4) |
| None | 405 (35.2) |
| PsO total treatment duration (years), median (range) | 3.5 (1.0–16.3) |
Total treatment duration = number of years between the first and the last treatment.
Abbreviations: BMI, body mass index; FAS, full analysis set; PsA: psoriatic arthritis; PsO, psoriasis; SD, standard deviation.